NTRB vs. SMTI, AVR, ZYXI, RCEL, ELMD, LAKE, NVRO, PROF, DRTS, and INGN
Should you be buying Nutriband stock or one of its competitors? The main competitors of Nutriband include Sanara MedTech (SMTI), Anteris Technologies Global (AVR), Zynex (ZYXI), AVITA Medical (RCEL), Electromed (ELMD), Lakeland Industries (LAKE), Nevro (NVRO), Profound Medical (PROF), Alpha Tau Medical (DRTS), and Inogen (INGN). These companies are all part of the "medical equipment" industry.
Nutriband vs.
Nutriband (NASDAQ:NTRB) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, community ranking, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.
Nutriband currently has a consensus target price of $13.00, suggesting a potential upside of 84.14%. Sanara MedTech has a consensus target price of $47.00, suggesting a potential upside of 47.38%. Given Nutriband's higher probable upside, research analysts clearly believe Nutriband is more favorable than Sanara MedTech.
In the previous week, Sanara MedTech had 1 more articles in the media than Nutriband. MarketBeat recorded 3 mentions for Sanara MedTech and 2 mentions for Nutriband. Sanara MedTech's average media sentiment score of 0.96 beat Nutriband's score of 0.44 indicating that Sanara MedTech is being referred to more favorably in the news media.
Sanara MedTech received 17 more outperform votes than Nutriband when rated by MarketBeat users. Likewise, 58.33% of users gave Sanara MedTech an outperform vote while only 44.44% of users gave Nutriband an outperform vote.
19.7% of Nutriband shares are owned by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are owned by institutional investors. 54.1% of Nutriband shares are owned by insiders. Comparatively, 54.1% of Sanara MedTech shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Nutriband has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500. Comparatively, Sanara MedTech has a beta of 1.57, meaning that its share price is 57% more volatile than the S&P 500.
Sanara MedTech has a net margin of -10.71% compared to Nutriband's net margin of -338.51%. Sanara MedTech's return on equity of -19.86% beat Nutriband's return on equity.
Sanara MedTech has higher revenue and earnings than Nutriband. Sanara MedTech is trading at a lower price-to-earnings ratio than Nutriband, indicating that it is currently the more affordable of the two stocks.
Summary
Sanara MedTech beats Nutriband on 12 of the 17 factors compared between the two stocks.
Get Nutriband News Delivered to You Automatically
Sign up to receive the latest news and ratings for NTRB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nutriband Competitors List
Related Companies and Tools
This page (NASDAQ:NTRB) was last updated on 3/4/2025 by MarketBeat.com Staff
Free NTRB Stock Alerts